Evidence mapPaperPMID 37874153Full record

ArticleJournal of virology2023

Host immunity associated with spontaneous suppression of viremia in therapy-naïve young rhesus macaques following neonatal SHIV infection.

Tyler D Evangelous, Madison Berry, Sravani Venkatayogi, Cas LeMaster, Eric S Geanes, Nicole De Naeyer, Todd DeMarco, Xiaoying Shen, Hui Li, Bhavna Hora and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Nonhuman primate models of pediatric viral diseases.Frontiers in cellular and infection microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Tyler D EvangelousDuke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina, USA.
Madison BerryDuke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina, USA.
Sravani VenkatayogiDuke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina, USA.
Cas LeMasterChildren's Mercy Kansas City , Kansas City, Missouri, USA.
Eric S GeanesChildren's Mercy Kansas City , Kansas City, Missouri, USA.
Nicole De NaeyerDuke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina, USA.
Todd DeMarcoDuke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina, USA.
Xiaoying ShenDuke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina, USA.ORCID 0000-0002-8387-3952
Hui LiPerelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania, USA.
Bhavna HoraDuke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina, USA.
Nicholas SolomonisBIOQUAL Inc. , Rockville, Maryland, USA.
Johnathan MisamoreBIOQUAL Inc. , Rockville, Maryland, USA.
Mark G LewisBIOQUAL Inc. , Rockville, Maryland, USA.
Thomas N DennyDuke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina, USA.
David MontefioriDuke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina, USA.
George M ShawPerelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania, USA.
Kevin WieheDuke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina, USA.
Todd BradleyChildren's Mercy Kansas City , Kansas City, Missouri, USA.
Wilton B WilliamsDuke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina, USA.ORCID 0000-0002-2970-7259
Duke University · USBioqual · USChildren's Mercy Hospital · USUniversity of Pennsylvania · US

Funding

Support for National Primate Research CenterP51OD011092 · OREGON HEALTH & SCIENCE UNIVERSITY · 2025 to 2025
$13.7M
Social and Behavioral Sciences CoreP30AI064518 · DUKE UNIVERSITY · 2005 to 2025
$4.4M
Virus and Antibody Gene Sequencing CoreP01AI131251 · UNIVERSITY OF PENNSYLVANIA · 2025 to 2025
$3.9M
Natural killer cell regulation of the germinal center HIV neutralizing antibody responseR01AI147778 · NIAID · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI Todd Christopher Bradley · 2021 to 2024
$2.8M
Reverse Vaccinology in SHIV Infected Macaques as a Molecular Guide for HIV-1 Vaccine DesignR01AI160607 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI GEORGE M SHAW · 2024 to 2024
$804k
HIV-1 Q23.17 Env: Engineering a novel immunogen to elicit broadly neutralizing antibodiesR01AI165080 · UNIVERSITY OF PENNSYLVANIA · 2025 to 2025
$804k
Viral Testing CoreU42OD010426 · OREGON HEALTH & SCIENCE UNIVERSITY · 2025 to 2025
$361k
NIAID NIH HHS HHSN272201800004CNIAID NIH HHS P01 AI131251NIAID NIH HHS P30 AI064518NIAID NIH HHS R01 AI140897NIAID NIH HHS R01 AI147778NIAID NIH HHS R01 AI160607NIAID NIH HHS R01 AI165080NIAID NIH HHS R56 AI147778NIH HHS P51 OD011092NIH HHS U42 OD010426
6 · The paper itself

Abstract

importanceDespite the advent of highly active anti-retroviral therapy, people are still dying from HIV-related causes, many of whom are children, and a protective vaccine or cure is needed to end the HIV pandemic. Understanding the nature and activation states of immune cell subsets during infection will provide insights into the immunologic milieu associated with viremia suppression that can be harnessed via therapeutic strategies to achieve a functional cure, but these are understudied in pediatric subjects. We evaluated humoral and adaptive host immunity associated with suppression of viremia in rhesus macaques infected soon after birth with a pathogenic SHIV. The results from our study provide insights into the immune cell subsets and functions associated with viremia control in young macaques that may translate to pediatric subjects for the design of future anti-viral strategies in HIV-1-infected infants and children and contribute to an understudied area of HIV-1 pathogenesis in pediatric subjects.

Indexed as

Animals, NewbornDisease Models, AnimalHIV InfectionsMacaca mulattaSimian Acquired Immunodeficiency SyndromeViremiaAnimalsChildHIVHumansSimian Immunodeficiency Viruscytokine profilingmacaque BCR sequencingmacaque TCR sequencingneonatal SHIV infectionsingle-cell transcriptomicsviral persistenceviremia control

Identifiers

PMID37874153
PMCPMC10688376
OpenAlexW4387893963

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.